Posted On: 11/20/2012 2:16:12 PM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Andrew W. replied to a question that patients in the study keep receiving Kevetrin as long as they want but that they only get the dosage they started with so patients in Cohort 1 will only get the low dose throughout the length of the trials.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)